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Abstract
Background: Ischemic stroke survivors have high risk of cardiovascular morbidity and mortality even at young age,
suggesting that early arterial aging is common among such patients.
Methods: We measured aortic stiffness by carotid-femoral pulse wave velocity (PWV) in 205 patients (69% men) aged 15–60
years with acute ischemic stroke in the prospective Norwegian Stroke in the Young Study. High for age carotid-femoral PWV
was identified in the reference normogram.
Results: Patients were on average 49610 years old, 34% had a history of hypertension and 37% had metabolic syndrome
(MetS). In the total study population, higher PWV was associated with history of hypertension (b= 0.18), higher age
(b= 0.34), systolic blood pressure (BP) (b= 0.28) and serum creatinine (b= 0.18) and lower high-density lipoprotein (HDL)
cholesterol (b= –0.10, all p,0.01) in multivariate linear regression analysis (multiple R2 = 0.42, p,0.001). High for age PWV
was found in 18% of patients. In univariate analyses, known hypertension was associated with a 6-fold, MetS with a 4-fold
and presence of carotid plaque with a 3.7-fold higher risk for high for age PWV (all p,0.01). In multiple logistic regression
analysis higher systolic BP (odds ratio [OR] 1.04; 95% confidence interval [CI] 1.02–1.06; p,0.01), history of hypertension (OR
3.59; 95% CI 1.52–8.51; p,0.01), low HDL cholesterol (OR 3.03; 95% CI 1.00–9.09; p = 0.05) and higher serum creatinine (OR
1.04; 95% CI 1.01–1.06; p,0.01) were associated with high for age PWV.
Conclusions: Higher PWV is common in younger and middle-aged ischemic stroke patients and associated with a clustering
of classical cardiovascular risk factors.
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Introduction
Risks for recurrent stroke, cognitive problems, cardiovascular
morbidity and mortality are high in young and middle-aged
patients with ischemic stroke [1,2]. Current American Heart
Association guidelines recommend extensive cardiovascular
screening in patients who experience stroke or a transient ischemic
attack to prevent recurrent ischemic stroke [3]. In particular
identification and management of traditional cardiovascular risk
factors, atrial fibrillation and other cardiac sources of systemic
cerebral embolism are important in secondary prevention to avoid
recurrent ischemic stroke. However, assessment of arterial stiffness
is not yet a part of the recommended screening in stroke patients
but may contribute to the understanding of the impaired prognosis
in patients with a first acute ischemic stroke ,50 years old [1,2].
Carotid-femoral pulse wave velocity (PWV) is a direct measure
of central arterial stiffness [4,5]. Hypertension, atherosclerosis and
arterial inflammation all lead to progressive arterial aging which
may be diagnosed as increased carotid-femoral PWV for age [6].
Increased arterial stiffness is a well-documented predictor of
cardiovascular morbidity and mortality in hypertensive patients as
well as in general populations [7,8]. Arterial stiffness has not been
much studied in stroke patients ,60 years, but smaller studies in
older stroke patients have indicated that increased arterial stiffness
is associated with impaired prognosis [9]. The aim of the present
study was to assess covariates of increased arterial stiffness in
patients #60 years with ischemic stroke participating in the
Norwegian Stroke in the Young Study (NOR-SYS).
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Methods
Patient population
The prospective NOR-SYS research program at the Depart-
ment of Neurology, Haukeland University Hospital, Bergen,
Norway includes patients aged 15–60 years, admitted with
documented acute ischemic stroke. The rationale, study design,
inclusion and exclusion criteria of NOR-SYS have been previously
published [10]. Between September 2010 and October 2013, a
total of 214 patients were included. Among these, 9 patients were
excluded from the present analyses due to presence or history of
atrial fibrillation. The subtype of acute ischemic stroke was
classified according to the Trial of ORG 10172 in Acute Stroke
Treatment (TOAST) criteria into Large Artery Atherosclerosis
(LAA), Cardio-Embolic Infarct (CEI), LACunar infarcts (LAC),
stroke of Other Determined Etiology (ODE), or stroke of
UnDetermined Etiology (UDE) [11].
The study was approved by the Regional Committee for
Medical Research Ethics of Western Norway, and conducted in
accordance with the Declaration of Helsinki. All patients or their
legal representatives signed a written informed consent.
Cardiovascular risk factors
A standardized questionnaire was used to obtain the patient’s
self-reported information about cardiovascular risk factors and
medication. Brachial blood pressure (BP) was measured in triplets
by the same investigator using a regularly calibrated aneroid
sphygmomanometers and appropriate cuff size earlier on the same
day of the arterial stiffness assessment [12]. An average of the last
two measurements was taken as the brachial BP. Known
hypertension was defined as history of hypertension or use of
antihypertensive drugs.
Body mass index (BMI) was calculated from body weight in
kilograms divided by height in meters squared. Obesity was
defined as BMI $30 kg/m2. Venous blood samples were drawn
for analysis of fasting serum lipids and glucose, serum sodium,
potassium and creatinine. Hypercholesterolemia was considered
present if total serum cholesterol .200 mg/dl, and/or low-density
lipoprotein (LDL) cholesterol .116.0 mg/dl. Low high-density
lipoprotein (HDL) cholesterol was defined as ,40 mg/dl (males)
and 50 mg/dl (females) [12].
Metabolic syndrome (MetS) was defined using the modified
American Heart Association/National Heart, Lung, and Blood
Institute criteria requiring presence of at least 3 of the 5 following
criteria: 1) waist circumference $102 cm (males) and $88 cm
(females); 2) triglycerides $150 mg/dl; 3) HDL cholesterol ,
40 mg/dl (males) and 50 mg/dl (females); 4) systolic BP $
130 mmHg and/or diastolic BP $85 mmHg measured at the time
of the PWV recording; and 5) fasting blood glucose $100 mg/dl
[13]. Diabetes mellitus was diagnosed as previously known
diabetes, use of anti-diabetic treatment, or fasting blood glucose
$126 mg/dl [14].
Pulse wave velocity
Carotid-femoral PWV was measured by the same investigator
using a SphygmoCor device (AtCor Medical, Sydney, West Ryde,
Australia) under standardized laboratory conditions after the
patients had rested for 15 minutes in supine position in a quiet
examination room with a stable temperature [15]. All measure-
ments were performed between 8 a.m. and 2 p.m. on average
51 days after the admission for the acute stroke. All patients fasted
for at least 2 hours prior to the measurement. During the
measurements, speaking or sleeping was not allowed. Pressure
pulse waveforms were obtained transcutaneously from the
common carotid artery and right femoral artery with simultaneous
recording of the electrocardiogram for synchronizing carotid and
femoral pulse wave times. Following the inborn quality control
indices, optimal curves were obtained from the visual inspection of
the waveforms. The foot of the wave was defined at the end of
diastole. The transit time was measured between the feet of the 2
waveforms using the intersecting tangent algorithm. The proximal
distance between the carotid site and the sternal notch, and the
Figure 1. PWV analysis from a study participant with high for age PWV, i.e. PWV above the age-adjusted normative values based
on healthy population (16).
doi:10.1371/journal.pone.0112814.g001
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distal distance between the sternal notch and the femoral site were
measured precisely. Carotid-femoral PWV was calculated as
distance (D) in meters between the 2 recording sites divided by
transit time (TT) in seconds (PWV = D/TT) [4]. All PWV values
were corrected for mean blood pressure. High for age PWV was
taken as PWV higher than age-adjusted normative values based on
a large study of 4001 healthy subjects (Figure 1) [16,17].
Carotid ultrasound
The carotid intima-media thickness (IMT) was measured by
carotid ultrasound as previously published [10]. Carotid plaque
was defined as focal IMT .1.5 mm [10,18].
Statistics
Statistical analyses were performed using the IBM SPSS
statistical program version 21 (IBM, Armonk, New York, USA).
Data are presented as mean 6 standard deviation for continuous
variables and as percentages for categorical variables. The study
population was divided into groups with normal and high for age
PWV. Comparison of groups was done by Student’s t-test and
Chi-squared test as appropriate. Comparison between the stroke
subtypes was done by analysis of variance (ANOVA) with Scheffe’s
post hoc test for PWV and a general linear model with Sidak’s post
hoc test for high for age PWV. The variable serum creatinine was
skewed and therefore log transformed. Univariate covariates of
PWV were identified by Pearson’s correlation coefficient and
univariate logistic regression analysis, as appropriate. Independent
covariates of PWV were identified in multivariate linear regression
Table 1. Baseline characteristics of the study population.
Total population Normal for age PWV High for age PWV
Number of patients, n 205 167 38
Age, y 49610 48610 5267**
Male sex, % 69 66 82*
Metabolic syndrome, % 37 31 64**
Obesity, % 24 20 42**
Smoking, % 46 46 47
Diabetes mellitus, % 13 10 29**
Antidiabetic treatment, % 7 4 16*
Known hypertension, % 34 26 68**
Antihypertensive treatment, % 22 19 39**
Systolic BP, mmHg 133619 129617 148621**
Diastolic BP, mmHg 81611 79610 88614**
Mean BP, mmHg 99613 96612 108615**
Pulse pressure, mmHg 52613 50612 60613**
PWV, m/sec 8.061.9 7.361.2 11.161.6**
Carotid plaque, % 11 8 24**
Creatinine, mg/dl 0.8560.39 0.7960.15 1.0760.85
Total cholesterol, mg/dl 213646 212642 224654
HDL cholesterol, mg/dl 54619 54619 46612**
LDL cholesterol, mg/dl 143642 139639 151646
Triglycerides, mg/dl 142689 133680 2046115**
Fasting blood glucose, mg/dl 103625 100618 118640*




Table 2. PWV and prevalence of high for age PWV in stroke subtypes according to the TOAST classification.
LAA CEI LAC ODE UDE p value
Number of patients, n 12 50 42 23 78
PWV, m/s 8.861.7 7.261.7 8.361.8 7.761.4 8.462.1* ,0.01
High for age PWV, % 25 12 21 17 20 ns
*p = 0.01 vs CEI. LAA: large-artery atherosclerosis; CEI: cardio-embolic infarct; LAC: lacunar infarct; ODE: stroke of other determined etiology; UDE: stroke of
undetermined etiology.
doi:10.1371/journal.pone.0112814.t002
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analysis and reported as standardized b-coefficients and p-values.
Covariates of high for age PWV were identified using uni- and
multivariate logistic regression analyses and reported as odds ratio
(OR) and 95% confidence intervals (CI). A p value #0.05 was




The total population was on average 49610 years old and
included 69% men, 37% with MetS, 34% with history of
hypertension, 13% with diabetes mellitus and 11% with carotid
plaques (Table 1). Common cardiovascular risk factors like
hypertension, diabetes mellitus, obesity, smoking and hypercho-
lesterolemia clustered in the study population, and 58% of patients
had at least 2 of these risk factors. PWV was numerically higher in
patients with LAA, LAC and UDE stroke subtypes, but differed
significantly only between UDE and CEI stroke subtypes (p,0.01)
(Table 2). Among the subpopulation of 134 (65%) patients who
underwent transesophageal echocardiography, 22% had a patent
foramen ovale (PFO). Among patients with PFO, 71% were
classified as CEI, 2% LAA, 5% LAC and 22% as UDE stroke
subtypes.
In the total study population, presence of carotid plaque was
associated with higher PWV (b= 0.25, p,0.001). Univariate
covariates of PWV in the total study population are presented in
Table 3. In the overall study population, history of hypertension
(b= 0.18), higher age (b= 0.34), systolic BP (b= 0.28) and serum
creatinine (b= 0.18), and lower HDL cholesterol (b= –0.10, all
p,0.05) were identified as independent covariates of higher PWV
in multivariate analysis (Table 4). In a secondary model, replacing
serum HDL cholesterol and history of hypertension with presence
of MetS, MetS was associated with higher PWV independent of
age, systolic BP and presence of carotid plaque (Table 4). No
association of the time interval between the acute stroke and the
PWV recording, or between new-onset or intensified antihyper-
tensive drug treatment during hospitalization for the acute stroke
and PWV was found.
Table 3. Covariates of PWV in univariate analyses in the total study population.
Variables Pearson’s correlation coefficient p value
Age, y 0.47 ,0.001
Systolic BP, mmHg 0.46 ,0.001
Diastolic BP, mmHg 0.35 ,0.001
Pulse pressure, mmHg 0.39 ,0.001
Mean BP, mmHg 0.44 ,0.001
Weight, kg 0.32 ,0.001
Body mass index, kg/m2 0.28 ,0.001
Waist circumference, cm 0.42 ,0.001
Total cholesterol, mg/dl 0.14 ,0.05
LDL cholesterol, mg/dl 0.19 ,0.01
HDL cholesterol, mg/dl –0.25 ,0.001
Triglycerides, mg/dl 0.29 ,0.001
Serum creatinine, mg/dl 0.28 ,0.001
Fasting blood glucose, mg/dl 0.29 ,0.001
HbA1c, % 0.37 ,0.001
doi:10.1371/journal.pone.0112814.t003
Table 4. Independent covariates of higher PWV in multivariate linear regression analyses.
Model 1* Model 2**
Variables Beta p value Beta p value
Age, y 0.34 ,0.001 0.38 ,0.001
Systolic BP, mmHg 0.28 ,0.001 0.32 ,0.001
Known hypertension 0.18 ,0.01 n.a. n.a.
Carotid plaque 0.05 0.39 0.09 0.10
Metabolic syndrome n.a. n.a. 0.15 ,0.05
Serum creatinine, mg/dl 0.18 ,0.01 0.12 ,0.05
HDL cholesterol, mg/dl –0.10 0.05 n.a. n.a.
n.a. = Not applicable. *multiple R2 0.42, p,0.01; **multiple R2 0.40, p,0.01*.
doi:10.1371/journal.pone.0112814.t004
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High for age PWV
High for age PWV was found in 18% of patients, and among
these 77% had a PWV .10 m/sec, the current guideline
recommended cut-off value for high PWV [12]. Compared to
patients with normal for age PWV, patients with high for age
PWV were older, dominated by males, had higher BP, serum
creatinine, fasting blood glucose and serum triglycerides and lower
plasma HDL cholesterol, as well as had more often known
hypertension, diabetes mellitus, obesity, MetS and carotid plaques
(all p,0.05) (Table 1). Clustering of cardiovascular risk factors like
hypertension, diabetes mellitus, obesity, smoking and hypercho-
lesterolemia was particularly high in this group: 87% of patients
with high for age PWV had at least 2 and 51% had at least 3 of
these risk factors. The prevalence of high for age PWV did not
differ between different TOAST subtypes of stroke (Table 2). In
univariate logistic regression analyses, known hypertension was
associated with a 6-fold (OR: 6.25 [95% CI 2.90–13.04], p,
0.001), MetS with a 4-fold (OR: 4.10 [95% CI 1.87–8.99], p,
0.001) and presence of carotid plaque with a 3.7-fold (OR: 3.70
[95% CI 1.45–9.45], p,0.01) higher risk for high for age PWV. In
multivariate analyses adjusting for systolic BP and serum
creatinine, having history of hypertension or MetS both were
independently associated with presence of high for age PWV in
different models (Table 5).
Discussion
Few studies have so far reported on arterial stiffness in ischemic
stroke patients [9,19,20]. To our knowledge, the present study is
the first to report on arterial stiffness and the association with
clustering of cardiovascular risk factors among young and middle-
aged ischemic stroke patients. In particular, high for age PWV was
found in 18% of patients and associated with higher systolic BP,
unfavorable serum lipid profile, history of hypertension and
presence of MetS and carotid plaques, reflecting atherosclerosis
detected by ultrasound.
The prevalence of high for age PWV in our population was
comparable to that reported from the general Danish population
in subjects, and therefore lower than expected [8]. Of note, 23% of
patients with high for age PWV had a PWV ,10 m/s, the
guideline-suggested threshold value for diagnosing target organ
damage.
The overall prevalence of hypertension in our population was
high, and hypertension was a main covariate of higher PWV in
young and middle-aged ischemic stroke patients in the present
study. Hypertension is a well-known risk factor for stroke and
increased arterial stiffness [7,21]. From the large Campania Salute
Network including more than 6000 hypertensive patients, higher
arterial stiffness was associated with higher prevalence of carotid
atherosclerotic plaques identified by ultrasound [22]. The present
study extends this association to young and middle-aged stroke
patients, by confirming the independent association of high for age
PWV and presence of pre-cerebral atherosclerosis.
Another striking finding in the present study was the clustering
of metabolic risk factors among young and middle-aged patients
with ischemic stroke, and in particular those with high for age
PWV. More than 50% of patients in this subgroup had at least 3
modifiable cardiovascular risk factors. This finding points to the
vast potential for both primary and secondary prevention to avoid
ischemic stroke as well as recurrent stroke in young and middle-
aged patients. Of note, only 58% of patients with high for age
PWV and known hypertension in the present study population
received antihypertensive treatment at the time of the ischemic
stroke.
Presence of MetS was associated with increased arterial stiffness
independent of systolic BP and history of hypertension in the
present study, adding to findings previously reported in older
ischemic stroke patients [19]. The amplification of age-associated
increase in arterial stiffness by MetS has been reported in a general
population using carotid ultrasound imaging to derive arterial
compliance [23]. Furthermore, an association between MetS and
subclinical atherosclerosis was previously reported in the Cardio-
vascular Risk in Young Finns Study including 2163 Finnish adults
below 40 years of age [24]. In their study, presence of MetS was
also associated with increased carotid artery intima-media
thickness and reduced carotid arterial compliance assessed with
ultrasound [24].
Low HDL cholesterol was associated with a 3-fold increased
presence of high for age PWV independent of hypertension and
systolic BP level in the present study. In several population-based
studies, lower HDL cholesterol has been associated with arterial
stiffness [25,26].
Increased carotid-femoral PWV has also been documented as
an independent predictor of mortality among diabetic patients
[27]. The overall prevalence of diabetes in NOR-SYS was 13%,
but twice as common in the high for age PWV group. The shared
effect of endothelial dysfunction, chronic low-grade inflammation,
glycation product formation and changes in structure of elastin
and collagen fibers in the arterial wall are all pathophysiological
mechanisms suggested to contribute to the increased arterial
stiffness in diabetes [28]. Of note, among patients with high for age
PWV in the present study population, only half of the diabetic
patients received glucose lowering agents at the time of the
Table 5. Independent covariates of high for age PWV in multiple logistic regression analyses.
Model 1 Model 2
Variables OR (95% CI) p value OR (95% CI) p value
Systolic BP, mmHg 1.04 (1.02–1.06) ,0.01 1.05 (1.02–1.07) ,0.01
Known hypertension 3.59 (1.52–8.51) ,0.01 n.a. n.a.
Carotid plaque 1.38 (0.45–4.27) 0.57 3.47 (1.05–11.44) ,0.05
Metabolic syndrome n.a. n.a. 2.59 (1.06–6.36) ,0.05
Low HDL-cholesterol 3.03 (1.00–9.09) 0.05 n.a. n.a.
Serum creatinine, mg/dl 1.04 (1.01–1.06) ,0.01 1.05 (1.02–1.08) ,0.01
n.a. = Not applicable.
doi:10.1371/journal.pone.0112814.t005
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ischemic stroke, pointing to the consequences of poor primary
cardiovascular prevention.
In conclusion, high for age PWV was found in 18% in this
prospective study of young and middle-aged ischemic stroke
patients, and particularly associated with the presence of
hypertension, MetS and carotid plaques. The clustering of
modifiable cardiovascular risk factors in young and middle-aged
stroke patients underline the vast potential for improving prognosis
in these patients by implementation of effective secondary
prophylaxis. Whether patients with high for age PWV are at
particular risk for future cardiovascular events should be
investigated in a larger study.
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